ArticleJuntendo medical journal2026
Association Analysis of Inter-Alpha-Trypsin Inhibitor Genes in Schizophrenia.
Article in Juntendo medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Schizophrenia (SCZ) is a common psychiatric disorder with relatively high morbidity and heritability. Affecting approximately 1% of the global population, SCZ is estimated to have an individual heritability of 60-85%. In recent years, several promising genetic loci have been identified using novel approaches such as genome-wide association studies (GWAS). Multiple GWAS have consistently reported that inter-alpha-trypsin inhibitor heavy chain (ITIH) family genes located on chromosome 3p21 are associated with SCZ in European populations, as demonstrated by the Schizophrenia Working Group of the Psychiatric Genomics Consortium and subsequent studies, as well as with bipolar disorder, another major psychotic disorder. Methods: In the present study, we conducted a case-control association analysis and haplotype analysis of single-nucleotide polymorphisms (SNPs) within the ITIH gene cluster at the 3p21 region to examine whether these variants confer genetic risk for schizophrenia in a Japanese population. In addition, we resequenced the ITIH1 gene to identify single-nucleotide variants (SNVs) and performed protein structural analyses to predict the effects of these variants on protein stability, aiming to clarify the potential contribution of ITIH1 to the pathophysiology of schizophrenia. Results: A significant difference in haplotype frequencies for the two-SNP window comprising rs2710322 and rs1042779 was observed. Resequencing identified 4 potentially deleterious variants. Conclusions: This study suggests a possible role of ITIH1 in the pathophysiology of schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.